Mt Baker Medical is excited to unveil its newly developed physician-supervised GLP-1 weight loss initiative, aimed at delivering safe and effective solutions for medical weight management. This ...

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long ...

The state, which is Maine's largest employer, will require employees to do health monitoring to retain insurance coverage.

The Food and Drug Administration on April 1 approved Eli Lilly's new weight-loss pill, giving consumers a second option in the growing non-injectable GLP-1 weight-loss drug market. Lilly said it will ...

GLP-1 weight-loss drugs have quickly become some of the most sought-after medications in the United States, but their price tags have also made them one of the most difficult benefits for employers ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

Weight-loss programs abound on the internet, from customized plans sold by influencers lacking credentials to subscription services offering access to GLP-1s and other medications. It can be tricky to ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, ...